Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: A prospective observational study

Acta Anaesthesiologica Belgica

Volumn 63, Issue 2, 2012, Pages 69-73

  Cammu, Guy ^a   Coart, D ^a   De Graeve, K ^a   Beelen, R ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

Heart failure; Neuromuscular block; Rocuronium; Sugammadex

Indexed keywords

CREATININE; ROCURONIUM; SUGAMMADEX;

ADDUCTOR POLLICIS MUSCLE; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CREATININE CLEARANCE; DEFIBRILLATOR; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; MALE; MUSCLE; NEUROMUSCULAR BLOCKING; PATIENT MONITORING;

ADOLESCENT; ADULT; AGED; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; BLOOD PRESSURE; CREATININE; DEFIBRILLATORS, IMPLANTABLE; ENDPOINT DETERMINATION; FEMALE; GAMMA-CYCLODEXTRINS; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; STROKE VOLUME; YOUNG ADULT;

EID: 84868542091     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hammill B. G., Curtis L. H., Bennett-Guerrero E., et al., Impact of heart failure on patients undergoing major noncardiac surgery, ANESTHESIOLOGY, 108, 559-567, 2008. (Pubitemid 351440575)
2. Hernandez A. F., Newby L. K., O'Connor C. M., Preoperative evaluation for major noncardiac surgery : focusing on heart failure, ARCH. INTERN. MED., 164, 1729-1736, 2004. (Pubitemid 39220340)
3. Matteo R. S., Ornstein E., Schwartz A. E., Ostapkovich N., Stone J. G., Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients, ANESTH. ANALG., 77, 1193-1197, 1993. (Pubitemid 23355210)
4. Van den Broek L., Proost J. H., Wierda J. M., Njoo M. D., Hennis P. J., Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block, EUR. J. ANAESTHESIOL., 11, 481-487, 1994. (Pubitemid 24354425)
5. Bom A., Hope F., Rutherford S., Thomson K., Preclinical pharmacology of sugammadex, J. CRIT. CARE, 24, 29-35, 2009.
6. Sorgenfrei I. F., Norrild K., Larsen P. B., et al., Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex : a dose-finding and safety study, ANESTHESIOLOGY, 104, 667-674, 2006.
7. Dahl V., Pendeville P. E., Hollmann M. W., Heier T., Abels E. A., Blobner M., Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery, EUR. J. ANAESTHESIOL., 26, 874-884, 2009.
8. Suzuki T., Kitajima O., Ueda K., Kondo Y., Kato J., Ogawa S., Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients, BR. J. ANAESTH., 106, 823-826, 2011.
9. McDonagh D. L., Benedict P. E., Kovac A. L., et al., Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients, ANESTHESIOLOGY, 114, 318-329, 2011.
10. Suresh D., Carter J. A., Whithead J. P., Goldhill D. R., Flynn P. J., Cardiovascular changes at antagonism of atracurium. Effects of different doses of premixed neostigmine and glycopyrronium in a ratio of 5:1, ANAESTHESIA, 46, 877-880, 1991.
11. Caldwell J. E., Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium, ANESTH. ANALG., 80, 1168-1174, 1995.
12. Muravchick S., Owens W. D., Felts J. A., Glycopyrrolate and cardiac dysrhythmias in geriatric patients after reversal of neuromuscular blockade, CAN. ANAESTH. Soc. J., 26, 22-25, 1979. (Pubitemid 9091638)
13. Feinberg M., The problems of anticholinergic adverse effects in older patients, DRUGS AGING, 3, 335-348, 1993.
14. Young W. L., Matteo R. S., Ornstein E., Duration of action of neostigmine and pyridostigmine in the elderly, ANESTH. ANALG., 67, 775-778, 1988.
15. Plaud B., Meretoja O., Hofmockel R., et al., Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients, ANESTHESIOLOGY, 110, 284-294, 2009.
16. Yoshida F., Suzuki T., Kashiwai A., Furuya T., Konishi J., Ogawa S., Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex, ACTA ANAESTHESIOL. SCAND., 56, 83-87, 2012.
17. Hudson M. E., Rothfield K. P., Tullock W. C., Firestone L. L., Haemodynamic effects of rocuronium bromide in adult cardiac surgical patients, CAN. J. ANAESTH., 45, 139-143, 1998. (Pubitemid 28191890)
18. Moore E. W., Hunter J. M., The new neuromuscular blocking agents : do they offer any advantages ?, BR. J. ANAESTH., 87, 912-925, 2001. (Pubitemid 33130285)
19. Baykara N., Solak M., Toker K., Predicting recovery from deep neuromuscular block by rocuronium in the elderly, J. CLIN. ANESTH., 15, 328-333, 2003. (Pubitemid 37162717)
20. Kumar N., Mirakhur R. K., Symington M. J., McCarthy G. J., Potency and time course of action of rocuronium during desflurane and isoflurane anaesthesia, BR. J. ANAESTH., 77, 488-491, 1996. (Pubitemid 26341036)
21. Staals L. M., Snoeck M. M., Driessen J. J., Flockton E. A., Heeringa M., Hunter J. M., Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function, BR. J. ANAESTH., 101, 492-497, 2008.